Zemcelpro® (UM171 Cell Therapy) licensing and supply agreements announced for Europe

الملخص

Partnership advances the global commercialization strategy for Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, following its conditional marketing authorisation in Europe from the European Commission.